Adult T-cell leukemia/lymphoma and acquired immunodeficiency syndrome - CD4+ T-cell malignancy in CD4+ T-cell deficient status: A paradox

CD4 counts along with viral loads are important parameters in the monitoring of human immunodeficiency virus (HIV) infection. Human T-cell lymphotropic virus type I (HTLV-I) is known to be an etiological agent for adult T-cell leukemia/lymphoma (ATLL). Coinfection of HTLV-I and HIV is well known in regions with high seroprevalence, and there is no published data in the Indian scenario. We present an interesting case of occurrence of CD4+ T-cell proliferation in a known beta thalassemia major with acquired HIV seropositivity accompanied by simultaneously increasing CD4+ counts and viral loads. Further workup revealed ATLL with an underlying HTLV infection.

[1]  Daniel C. Douek,et al.  CD127 and CD25 Expression Defines CD4+ T Cell Subsets That Are Differentially Depleted during HIV Infection 1 , 2008, The Journal of Immunology.

[2]  H. Kumar,et al.  Is seroprevalence of HTLV-I/II among blood donors in India relevant? , 2006, Indian journal of pathology & microbiology.

[3]  H. Moon,et al.  Role of HIV Vpr as a regulator of apoptosis and an effector on bystander cells. , 2006, Molecules and cells.

[4]  D. Nixon,et al.  CD4+CD25+ regulatory T cells in HIV infection. , 2005, Microbes and infection.

[5]  Mario Roederer,et al.  T-Cell Subsets That Harbor Human Immunodeficiency Virus (HIV) In Vivo: Implications for HIV Pathogenesis , 2004, Journal of Virology.

[6]  J. Scapellato,et al.  CD4 cell count among HIV-infected patients with an AIDS-defining disease: higher count in patients coinfected than in those not coinfected with human T-cell lymphotropic virus type I. , 2003, Journal of acquired immune deficiency syndromes.

[7]  I. Al-Sheikh,et al.  Seroepidemiological prevalence of human T-cell lymphotropic virus type I (HTLV-I) among healthy blood donors in Eastern Saudi Arabia. , 1998, Annals of Saudi medicine.

[8]  B. Marsh Coinfection with human T lymphotropic virus type I and human immunodeficiency virus. , 1997, The Journal of infectious diseases.

[9]  T. Quinn,et al.  Human T cell lymphotropic virus type I does not increase human immunodeficiency virus viral load in vivo. , 1997, The Journal of infectious diseases.

[10]  M. C. Bach,et al.  Management of coinfection with human immunodeficiency virus and human T-cell lymphotropic virus type I. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  H. Lederman,et al.  Immunodeficiency and elevated CD4 T lymphocyte counts in two patients coinfected with human immunodeficiency virus and human lymphotropic virus type I. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[12]  T. Quinn,et al.  Coinfection with human T-cell lymphotropic virus type I and HIV in Brazil. Impact on markers of HIV disease progression. , 1994, JAMA.

[13]  K. Yamaguchi,et al.  Adult T cell leukaemia-lymphoma. , 1993, Bailliere's clinical haematology.

[14]  W. Blattner,et al.  Does human T-cell lymphotropic virus type I and human immunodeficiency virus type 1 coinfection accelerate acquired immunodeficiency syndrome? The jury is still out. , 1992, Archives of internal medicine.

[15]  T. M. Hartley,et al.  Seroprevalence of HTLV-1 and HTLV-2 among intravenous drug users and persons in clinics for sexually transmitted diseases. , 1992, The New England journal of medicine.